Noveome Biotherapeutics
PrivateLast Round
Seed Round
Aug 27, 2026
Total Funding Raised
$185.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Noveome Biotherapeutics is a biotechnology company that develops novel biotherapeutic products aimed at treating inflamed or damaged tissues through a synergistic combination of biologic components.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noveome Biotherapeutics Comparables
Compare Noveome Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Secretome Therapeutics | 85% | |
| Plakous Therapeutics | 82% | |
| Direct Biologics | 81% | |
Noveome Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 27, 2026 | ||||
| Series E | Apr 23, 2025 | ||||
| Grant | Jun 23, 2021 | ||||
| Grant | May 7, 2020 | ||||
| Series D | Apr 9, 2019 | ||||
Grant | Apr 3, 2018 |
Key People
Founding team and executive leadership
Noveome Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pittsburgh Investment Office | Seed |
| Carnegie Mellon University Investment Office | Seed |
| Miraki | Series E |
| U.S. Department of War | Grant |
| Commonwealth of Pennsylvania | Grant |
| MAK Capital One | Series E |
| Lancet Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Raised $7M in a Seed Round.
- Apr 23, 2025
$51M round led by MAK Capital One.
Noveome Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Noveome Biotherapeutics's valuation, stock price, and market status.